InvestorsHub Logo
Followers 65
Posts 7242
Boards Moderated 0
Alias Born 03/06/2016

Re: gbrown6332 post# 37251

Thursday, 10/05/2017 12:57:57 PM

Thursday, October 05, 2017 12:57:57 PM

Post# of 108192
grown -

I believe researchers are well aware of the human applications for HER2 and the broader implications if it's successful treating canine osteosarcoma


And that is exactly what I believe Lombardo is betting on. Concentrate resources on AXAL and when PETX gets its approval....then HER2 will be put up for sale. Approval for canine, will increase the selling price. If AXAL gets EU approval, it my also make sense to sell the license agreement with PetX. Sell the future revenue stream from royalties along with HER2. The buyer and seller both win (and shareholders too).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News